🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to confirm the safety and tolerability of elra...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2021-03-22
Trial ID
NCT04798586
Treatments Being Tested
The purpose of this study is to evaluate: * What is the real-world effecti...
Status
Active Not Recruiting
Location
Kaohsiung Chang Gung Memorial Hospital
Start Date
2026-05-11
Trial ID
NCT07391761
Treatments Being Tested
The main purpose of the study is to understand the safety and tolerability ...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2026-02-06
Trial ID
NCT07280013
Treatments Being Tested
The purpose of the study is to evaluate whether single-agent Elranatamab (P...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2021-02-02
Trial ID
NCT04649359
Treatments Being Tested
This is a post-trial access (PTA) open-label, single-arm study in Multiple ...
Status
Recruiting
Location
UCI Health - Irvine Infusion Pharmacy ACC
Start Date
2023-10-03
Trial ID
NCT06057402
Treatments Being Tested
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136
Lenalidomide is a standard of care for maintenance therapy after autologous...
Status
Not Yet Recruiting
Location
CHU Angers
Start Date
2025-05-01
Trial ID
NCT06931704
Treatments Being Tested
The goal of this clinical trial is to find out how well a combination of tw...
Status
Recruiting
Location
National University Hospital (NUH)
Start Date
2024-11-26
Trial ID
NCT06645678
Treatments Being Tested
A phase II study of single agent elranatamab in patients with relapsed and/...
Status
Recruiting
Location
Vancouver Cancer Center
Start Date
2025-03-28
Trial ID
NCT06421675
Treatments Being Tested
Bispecific antibody (BsAb) treatments, teclistamab and elranatamab, are new...
Status
Completed
Location
Assistance Publique - Hôpitaux de Paris (AP-HP)
Start Date
2022-07-01
Trial ID
NCT06359067